Arterial Vascular Engineering AVEI Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Arterial Vascular Engineering AVEI

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Carl Yee who wrote (287)	7/22/1998 2:10:00 PM
From: Boris Maleshev	Read Replies (1) of 410

Arterial Vascular Engineering Inc. (AVEI) 44 3/8 +1 1/16: Adams Harkness upgrades stent maker from "market perform" to "buy" as highly rated gfx and gfx II stents should propel earnings to higher-than-anticipated levels; has an 18-month price target of $98 and earnings projections of $2.80 a share for FY99 and $3.67 a share for FY00.....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next